Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gut metagenome

ABSTRACT: Metagenomic next-generation sequencing of Graft-versus-Host disease

PROVIDER: PRJNA396964 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5926450.fastq.gz	Fastqsanger.gz
	SRR5926460.fastq.gz	Fastqsanger.gz
	SRR5926470.fastq.gz	Fastqsanger.gz
	SRR5926480.fastq.gz	Fastqsanger.gz
	SRR5926490.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 600

Similar Datasets

mouse gut metagenome

Project description:Study of Intestinal microbiota in graft-versus-host disease

| PRJDB4167 | ENA

gut metagenome

Project description:Fecal microbiota transplantations reconstitute gut fungal and viral microbiota in graft-versus-host disease

| PRJNA515137 | ENA

Next generation sequencing transcriptome analysis of colonic epithelial cells from bone marrow transplant recipient mice

Project description:Alloimmune T cell mediated gastrointestinal graft-versus-host disease (GI-GVHD) occur after bone marrow translantation (BMT). GI-GVHD cause significant morbidity and mortality. Immunosuppression therapies have shown good results with adverse effects, but are still incomplete. The biology of GVHD are often understood from the immune cell perspectve, but the pathogenesis and severity from host IEC traget cell perspective remain undefined. We used next generation sequencing transcriptome to detail the gene expression of colonic epithelial cells underlying the profile changes between the syngeneic recipient and allogeneic recipient.

2021-04-01 | GSE158259 | GEO

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Project description:RATIONALE: Beclomethasone may be an effective treatment for graft-versus-host disease. PURPOSE: Phase I/II trial to study the effectiveness of beclomethasone in treating patients who have graft-versus-host disease of the esophagus, stomach, small intestine, or colon.

| 2005776 | ecrin-mdr-crc

human gut metagenome

Project description:Fecal microbiota transplantation for the gastrointestinal steroid-refractory graft-versus host disease using frozen capsule.

| PRJDB7070 | ENA

mouse gut metagenome

Project description:Impacts of Intestinal microbiota on graft-versus-host disease and engraftment after hematopoietic stem cell transplant

| PRJDB5102 | ENA

human metagenome

Project description:Metagenomic Next-Generation Sequencing for Infectious Disease Diagnosis

| PRJNA298217 | ENA

The effect of LCN2 treatment on anti-inflammatory bone marrow derived macrophages

Project description:Allogeneic hematopoietic stem cell transplantation remains the most efficacious treatment for many hematological malignancies. However, its therapeutic potential is affected by the most prominent side effect graft versus host disease. Despite advances in the treatment of graft versus host disease in recent years, morbidity and mortality remains high, which requires the development of new treatment approaches. We therefore implemented mouse models to assess potential treatment options for graft versus host disease. In in vivo experiments, we had observed a protective effect of LCN2 on graft versus host disease of the gastrointestinal tract. We also observed higher numbers of anti-inflammatory macrophages in the intestinal tissues of these animals. Therefore, we aimed to determine potentially regulated genes in these cells by using an in vitro approach of LCN2-treated macrophages.

2024-01-24 | GSE226432 | GEO

Homo sapiens

Project description:Acute graft-versus-host disease (gene expression profiling)

| PRJNA100457 | ENA